ArticleScientific reports2025

Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells.

Tsung-Han Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.